Patent details

Basic Information

Publication number:

EP4188418

PCT Application Number:

US2021042531

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP217628395

PCT Publication Number:

WO2022031440

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

DRUG-SPECIFIC PHARMACOKINETIC ASSAY FOR IL-15 SUPERAGONIST

French Title of Invention:

DOSAGE PHARMACOCINÉTIQUE SPÉCIFIQUE D'UN MÉDICAMENT POUR UN SUPERAGONISTE D'IL-15

German Title of Invention:

ARZNEIMITTELSPEZIFISCHER PHARMAKOKINETISCHER TEST FÜR IL-15-SUPERAGONIST

SPC Number:

Dates

Filing date:

21/07/2021

Grant date:

02/04/2025

EP Publication Date:

07/06/2023

PCT Publication Date:

10/02/2022

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/04/2025

EP B1 Publication Date:

02/04/2025

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

21/07/2041

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

26/03/2025

 

 

Name:

Nantcell, Inc.

Address:

9920 Jefferson Boulevard, Culver City, California 90232, United States (US)

Inventor

1

Name:

TANAKA, Shiho

Address:

United States (US)

2

Name:

NIAZI, Kayvan

Address:

United States (US)

Priority

Priority Number:

202063060256 P

Priority Date:

03/08/2020

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/20; G01N 33/50;

Publication

European Patent Bulletin

Issue number:

202514

Publication date:

02/04/2025

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

31/07/2025

Annual Fee Number:

5

Annual Fee Amount:

52 Euro

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages